Welcome To ChemAnalyst
US chloroform values declined by 1.4% in late June 2026 as chloroform prices remained under pressure from subdued downstream demand and comfortable supply conditions. The market experienced muted trading activity as buyers maintained cautious procurement while producers faced subdued intake against adequate inventories and stable feedstock availability. Demand for chloroform remained mixed across end-use sectors, with refrigerant formulators reducing consumption under the EPA’s HCFC-22 cap, while pharmaceutical and fluoropolymer manufacturers continued purchasing at routine volumes. Agrochemical and specialty chemical demand for chloroform remained moderate, and export activity was mixed. On the supply side, steady chlorine availability, stable methane and methanol costs, and comfortable inventories ensured ample market availability, limiting upward price pressure. Looking ahead, the near-term outlook for remains cautious as comfortable supply and moderate downstream demand are expected to keep prices largely stable, with regulatory developments and feedstock cost movements remaining the key factors to watch.
Chloroform values in the United States declined in late June 2026, prices falling by 1.4% as subdued downstream demand and comfortable supply conditions weighed on the market. Following the weakness seen in late May, the chloroform market remained under pressure throughout June as buyers maintained cautious procurement and spot offers softened. Overall, producers faced subdued intake rather than acute oversupply, and the pace of transactions remained muted against a background of comfortable chloroform inventories and steady feedstock availability.
Demand dynamics for chloroform reflected a mixed patchwork across end-use sectors. Refrigerant formulators particularly those tied to HCFC-22 continued to curb production in line with the EPA’s 2026 consumption cap, which capped captive demand and left this sector comparatively soft. In contrast, pharmaceutical and fluoropolymer users continued to purchase at normal run-rate volumes, providing a steadier, though not growing, demand base. Agrochemicals and specialty chemical manufacturers registered moderate chloroform consumption, while export buyers diverged regionally: Brazilian solvent blenders maintained routine purchases but lost urgency to pre-buy amid currency movements, and Mexican buyers delayed chloroform tenders as finished-goods inventories remained comfortable. These demand patterns collectively restrained upward pressure on offers during June.
On the supply side, production and feedstock dynamics were broadly supportive of lower prices. Gulf Coast chlor-alkali units operated without weather-related interruptions, ensuring steady chlorine availability for chloroform production, while shale gas-derived methane and methanol costs remained stable, helping restrain production cost volatility. Merchant inventories at coastal terminals remained near long-term averages, allowing suppliers to meet routine liftings without resorting to spot imports. No major chloroform plant outages or logistics disruptions were recorded during June, leaving physical availability comfortable and limiting sellers' ability to push for higher bids.
Weekly trend data reflected the subdued chloroform market throughout June. After the weakness observed in late May, prices remained largely range-bound in late June, with week-over-week assessments showing only narrow fluctuations. Buyers continued purchasing chloroform at routine rates, while sellers largely defended existing offers amid balanced supply and demand conditions. The absence of any major supply disruptions or significant demand recovery reinforced the overall monthly decline in chloroform prices rather than triggering further volatility.
Looking ahead, the near-term outlook for chloroform remains mixed, with comfortable supply and cautious downstream demand expected to keep chloroform prices under pressure in the coming months. Key drivers include softer refrigerant-sector chloroform consumption under the EPA cap, steady pharmaceutical and fluoropolymer demand, and generally stable feedstock costs, although geopolitical risks affecting methane or LNG benchmarks could introduce upside cost pressure if energy markets strengthen. Based on current market trends and subject to prevailing market conditions, the chloroform market is expected to remain largely stable, with seasonal demand shifts and regulatory developments likely to be the primary catalysts for future price movements.
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
